Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jean-Baptiste Alberge, Ph.D.

Concepts (82)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma16202551861.250 Why?
5-Methylcytosine120201470.690 Why?
Regulatory Sequences, Nucleic Acid120207920.540 Why?
Monoclonal Gammopathy of Undetermined Significance320241760.530 Why?
Fluorodeoxyglucose F181202220280.420 Why?
Genome1202017520.400 Why?
Proto-Oncogene Proteins c-myc220249980.280 Why?
Dexamethasone2202519630.270 Why?
Immunotherapy, Adoptive3202415020.230 Why?
Boron Compounds120251950.210 Why?
Glycine120256700.190 Why?
Cyclin D212020970.180 Why?
Thiophenes120245700.170 Why?
Paraproteinemias120222510.160 Why?
Cyclin D1120204530.150 Why?
Histocompatibility Antigens Class I1202413620.150 Why?
Enhancer Elements, Genetic1202413660.150 Why?
Gene Expression Regulation, Neoplastic2202486280.130 Why?
Neoplasm, Residual1202210120.130 Why?
Neoplastic Cells, Circulating120239490.130 Why?
Histone-Lysine N-Methyltransferase120206990.130 Why?
Killer Cells, Natural1202422090.120 Why?
Lymphoma1202418960.120 Why?
Epigenomics120209590.120 Why?
Epigenesis, Genetic3202438280.110 Why?
T-Lymphocytes, Cytotoxic1202018010.100 Why?
Radiopharmaceuticals1202227020.100 Why?
Pyrimidines1202430440.100 Why?
Antineoplastic Agents22024136500.090 Why?
Plasma Cells220245990.090 Why?
Repressor Proteins1202029790.080 Why?
Chromatin1202029800.080 Why?
Proto-Oncogene Proteins c-bcl-22202414050.070 Why?
Cell Line, Tumor42024170970.070 Why?
DNA Methylation1202044260.070 Why?
Gene Expression Profiling1202295320.060 Why?
Antineoplastic Combined Chemotherapy Protocols12025118720.060 Why?
Humans1720257670400.050 Why?
Interferon Regulatory Factors120242710.050 Why?
bcl-2-Associated X Protein120242810.050 Why?
Severity of Illness Index12020159250.050 Why?
Phenotype12020167180.050 Why?
Bone Marrow2202329260.050 Why?
Disease Progression32025136460.050 Why?
Antibodies, Bispecific120242040.050 Why?
Receptors, Glucocorticoid120233090.050 Why?
Melanoma1202057020.050 Why?
Cytotoxicity, Immunologic1202413520.040 Why?
Tumor Microenvironment2202439440.040 Why?
Immunologic Memory1202413770.040 Why?
Apoptosis2202495130.040 Why?
Mice, Inbred NOD1202018370.030 Why?
Antibodies1202324190.030 Why?
Random Allocation1202023940.030 Why?
Neoplasm Recurrence, Local2202394100.030 Why?
Biological Products120249480.030 Why?
Mass Spectrometry1202222010.030 Why?
DNA Copy Number Variations1202320470.030 Why?
Mice, SCID1202026260.030 Why?
Glucocorticoids1202321630.030 Why?
Tumor Suppressor Protein p531202429520.030 Why?
Cell Transformation, Neoplastic1202228430.030 Why?
Transfection1202057530.020 Why?
Base Sequence12023124140.020 Why?
Xenograft Model Antitumor Assays1202036080.020 Why?
Female420253966600.020 Why?
Middle Aged220252232330.020 Why?
Cell Line12024155670.020 Why?
Male320253642030.020 Why?
Immunotherapy1202347450.020 Why?
T-Lymphocytes12024102540.020 Why?
Membrane Proteins1202378680.020 Why?
Prevalence12022158510.010 Why?
Obesity12024130850.010 Why?
Animals220241689650.010 Why?
Aged, 80 and over12025595480.010 Why?
Cohort Studies12022417180.010 Why?
Treatment Outcome12025652950.010 Why?
Risk Factors12024748860.010 Why?
Mice12020819120.010 Why?
Aged120251713190.010 Why?
Adult120252233170.010 Why?
Alberge's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.